Get started
Award

MU 3629/6‐1

Funded outputs count: 20
Funder award ID: MU 3629/6‐1
OpenAlex ID: G1164437396
MEDA-PKD: a dynamic, real-time analytics platform for precision care in autosomal dominant polycystic kidney disease
2026 · Franziska Grundmann, Sita Arjune, et al. · npj Digital Medicine
PDF
Urine Proteomics as a Source of Biological Information and Outcome Predictor in Living Kidney Transplantation
2026 · K. Johanna R. Hoyer-Allo, Patrick Affeldt, et al. · Molecular & Cellular Proteomics
PDF
Blood Proteomic Biomarkers indicate reduced system and tissue level inflammation responses to The GOTO Lifestyle Intervention in Older Adults
2025 · F.A. Bogaards, T. Gehrmann, et al. · medRxiv
PDF
Developing serum proteomics based prediction models of disease progression in ADPKD
2025 · Hande Ö. Aydogan Balaban, Sita Arjune, et al. · Nature Communications · 8
PDF
Liver manifestations in autosomal dominant polycystic kidney disease (ADPKD) and their impact on quality of life
2024 · Sita Arjune, Polina Todorova, et al. · Clinical Kidney Journal · 11
PDF
Inflammatory Cytokine Levels in Patients with Autosomal Dominant Polycystic Kidney Disease
2024 · Sita Arjune, Katharina Lettenmeier, et al. · Kidney360 · 11
Matrix Metalloproteinase-7 in Urinary Extracellular Vesicles Identifies Rapid Disease Progression in Autosomal Dominant Polycystic Kidney Disease
2023 · Martijn H. van Heugten, Charles J. Blijdorp, et al. · Journal of the American Society of Nephrology · 18
PDF
Refeeding-associated AMPKγ1 complex activity is a hallmark of health and longevity
2023 · Roberto Ripa, Eugen Ballhysa, et al. · Nature Aging · 43
PDF
Feasibility and impact of ketogenic dietary interventions in polycystic kidney disease: KETO-ADPKD—a randomized controlled trial
2023 · Sadrija Cukoski, Christoph Heinrich Lindemann, et al. · Cell Reports Medicine · 76
DKK3 as a potential novel biomarker in patients with autosomal polycystic kidney disease
2023 · Sita Arjune, Martin R Späth, et al. · Clinical Kidney Journal · 11
PDF
Emerging principles of primary cilia dynamics in controlling tissue organization and function
2023 · Jay Gopalakrishnan, Kerstin Feistel, et al. · The EMBO Journal · 82
PDF
Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients
2023 · Patrick Affeldt, Karl August Brensing, et al. · Clinical Kidney Journal · 3
PDF
Copeptin in autosomal dominant polycystic kidney disease: real-world experiences from a large prospective cohort study
2023 · Sita Arjune, Simon Oehm, et al. · Clinical Kidney Journal · 10
PDF
Ageing-associated changes in transcriptional elongation influence longevity
2023 · Cédric Debès, Antonios Papadakis, et al. · Nature · 204
PDF
The Importance of Lifestyle Interventions in the Prevention and Treatment of Chronic Kidney Disease
2023 · Ellen M. Castle, Sharlene A. Greenwood, et al. · Kidney and Dialysis · 5
PDF
A Low-Cost Sequencing Platform for Rapid Genotyping in ADPKD and its Impact on Clinical Care
2022 · Christoph Heinrich Lindemann, Andrea Wenzel, et al. · Kidney International Reports · 5
PDF
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant Recipients
2022 · Patrick Affeldt, Felix Carlo Koehler, et al. · Viruses · 26
PDF
RESET-PKD: a pilot trial on short-term ketogenic interventions in autosomal dominant polycystic kidney disease
2022 · Simon Oehm, Konstantin Steinke, et al. · Nephrology Dialysis Transplantation · 45
PDF
Microvascular perfusion, perfused boundary region and glycocalyx shedding in patients with autosomal dominant polycystic kidney disease: results from the GlycoScore III study
2022 · Alexander Fuchs, Jennifer Dederichs, et al. · Clinical Kidney Journal · 10
PDF
Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study
2022 · Piotr Woznicki, Florian Siedek, et al. · Kidney360 · 15
Year
Topic